Sub Banner Image

Why Is Biohaven Stock Falling On Thursday?

Market Impact

Vandana Singh

·

May 15, 2025

·

Benzinga

Biohaven secures $250 million from Oberland Capital, with total cash reaching $518 million to support troriluzole launch and operations.

Latest Ratings for BHVN

DateFirmActionFromTo
Mar 2022MizuhoMaintainsBuy
Jan 2022Morgan StanleyMaintainsEqual-Weight
Nov 2021MizuhoMaintainsBuy

View More Analyst Ratings for BHVN

View the Latest Analyst Ratings

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.